本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kalvista Pharmaceuticals Inc

16.01
+0.22001.39%
盘后15.86-0.1370-0.86%19:53 EDT
成交量:188.57万
成交额:3,013.90万
市值:7.97亿
市盈率:-4.33
高:16.20
开:15.75
低:15.59
收:15.79
数据加载中...
2023/06/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/14

重要事件披露

Form 8-K - Current report
2023/03/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/09

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/31

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/01/05

重要事件披露

8-K - Current report
2022/12/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/27

重要事件披露

8-K - Current report
2022/12/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/12/08

重要事件披露

8-K - Current report